Correlation Between IGM Biosciences and Monte Rosa

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IGM Biosciences and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IGM Biosciences and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IGM Biosciences and Monte Rosa Therapeutics, you can compare the effects of market volatilities on IGM Biosciences and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IGM Biosciences with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of IGM Biosciences and Monte Rosa.

Diversification Opportunities for IGM Biosciences and Monte Rosa

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between IGM and Monte is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding IGM Biosciences and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and IGM Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IGM Biosciences are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of IGM Biosciences i.e., IGM Biosciences and Monte Rosa go up and down completely randomly.

Pair Corralation between IGM Biosciences and Monte Rosa

Given the investment horizon of 90 days IGM Biosciences is expected to under-perform the Monte Rosa. But the stock apears to be less risky and, when comparing its historical volatility, IGM Biosciences is 1.04 times less risky than Monte Rosa. The stock trades about -0.59 of its potential returns per unit of risk. The Monte Rosa Therapeutics is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  948.00  in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would lose (102.00) from holding Monte Rosa Therapeutics or give up 10.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

IGM Biosciences  vs.  Monte Rosa Therapeutics

 Performance 
       Timeline  
IGM Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in IGM Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating primary indicators, IGM Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Monte Rosa Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

IGM Biosciences and Monte Rosa Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IGM Biosciences and Monte Rosa

The main advantage of trading using opposite IGM Biosciences and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IGM Biosciences position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.
The idea behind IGM Biosciences and Monte Rosa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios